United States Biotechnology & Medical Research

Senestech Inc (SNES)

Track

Track

Senestech Inc. witnessed nine insider trading transactions over the past ninety days, all representing purchases. Chief Executive Officer Michael Edell and Glenbrook Capital Management acquired shares totaling approximately $85,943. This activity follows an August earnings report where the firm beat expectations by 5.4%, despite a 56.4% decline in stock value during the recent quarter.
Ticker: SNES Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Senestech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
366.45
Quantity 96,916 +5.6%
Value US$1,181,795
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
260.56
Quantity 44,954 -42.4%
Value US$2,120,183
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
122.07
Quantity 30,683 -27.4%
Value US$3,432,691
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
0.89
Quantity 1,000 +16.7%
Value US$890
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.21
Quantity 1,000 +20.0%
Value US$1,210
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.43
Quantity 1,000 +25.0%
Value US$1,430
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.55
Quantity 1,000 +33.3%
Value US$1,550
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.55
Quantity 1,000 +33.3%
Value US$1,550
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.62
Quantity 1,000 +50.0%
Value US$1,615
1.1
Edell Michael Chief Executive Officer Executive Director
Transaction date
Purchase
Price
1.70
Quantity 2,000 +inf%
Value US$3,398
2.9
Leach Jacob Steven Non-Executive Director
Transaction date
Sale
Price
2.71
Quantity 62 -100.0%
Value US$168
2.3
Szot Matthew K Non-Executive Director
Transaction date
Sale
Price
2.75
Quantity 1 -100.0%
Value US$3
Mayer Loretta Powers Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
0.83
Quantity 6,000 -1.8%
Value US$4,980
Dyer Cheryl Ann Pres. & Chief Research Officer
Transaction date
Planned sale
Price
0.93
Quantity 6,000 -1.6%
Value US$5,575
Mayer Loretta Powers Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.19
Quantity 20,000 -5.1%
Value US$23,734
Dyer Cheryl Ann Pres. & Chief Research Officer Officer
Transaction date
Sale
Price
1.21
Quantity 20,000 -5.0%
Value US$24,100
Mayer Loretta Powers Chief Scientific Officer Executive Director
Transaction date
Sale
Price
1.24
Quantity 20,000 -4.9%
Value US$24,756
Dyer Cheryl Ann Pres. & Chief Research Officer Officer
Transaction date
Sale
Price
1.18
Quantity 20,000 -4.8%
Value US$23,622
0.6
SIEGEL KENNETH S CEO Executive Director
Transaction date
Purchase
Price
1.35
Quantity 696,296 +11119.4%
Value US$940,000
Williams Julia Ann Non-Executive Director
Transaction date
Purchase
Price
1.15
Quantity 1,000 +25.0%
Value US$1,150
Williams Julia Ann Non-Executive Director
Transaction date
Purchase
Price
1.15
Quantity 6,000 +4.3%
Value US$6,900
Williams Julia Ann Non-Executive Director
Transaction date
Purchase
Price
1.15
Quantity 4,000 +100.0%
Value US$4,600
Mayer Loretta Powers CEO & Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
2.13
Quantity 6,000 -1.5%
Value US$12,780
Mayer Loretta Powers CEO & Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
0.67
Quantity 6,000 -1.5%
Value US$4,026
Dyer Cheryl Ann Pres. & Chief Research Officer Executive Director
Transaction date
Planned sale
Price
0.82
Quantity 6,000 -1.5%
Value US$4,921
Williams Julia Ann
Transaction date
Purchase
Price
0.90
Quantity 1,700 +7.7%
Value US$1,525
Mayer Loretta Powers CEO & Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
0.89
Quantity 6,000 -1.5%
Value US$5,363
Dyer Cheryl Ann Pres. & Chief Research Officer Executive Director
Transaction date
Planned sale
Price
2.72
Quantity 6,000 -1.5%
Value US$16,339
Mayer Loretta Powers CEO & Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
1.52
Quantity 6,000 -1.5%
Value US$9,126
Dyer Cheryl Ann Pres. & Chief Research Officer Executive Director
Transaction date
Planned sale
Price
1.97
Quantity 6,000 -1.3%
Value US$11,808
Mayer Loretta Powers CEO & Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
1.79
Quantity 6,000 -1.5%
Value US$10,740
Dyer Cheryl Ann Pres. & Chief Research Officer Executive Director
Transaction date
Planned sale
Price
2.31
Quantity 6,000 -1.4%
Value US$13,834
Mayer Loretta Powers CEO & Chief Scientific Officer Executive Director
Transaction date
Planned sale
Price
2.37
Quantity 6,000 -1.5%
Value US$14,221
Altman Andrew Chief Operating Officer
Transaction date
Purchase
Price
2.46
Quantity 2,028 +11.3%
Value US$4,987
Williams Julia Ann
Transaction date
Purchase
Price
2.80
Quantity 9,000 +74.7%
Value US$25,200
Altman Andrew Chief Operating Officer
Transaction date
Purchase
Price
2.81
Quantity 14,372 +399.2%
Value US$40,332
Williams Julia Ann
Transaction date
Purchase
Price
2.75
Quantity 100 +0.8%
Value US$275
Altman Andrew Chief Operating Officer
Transaction date
Purchase
Price
2.82
Quantity 1,000 +38.5%
Value US$2,820
Altman Andrew Chief Operating Officer
Transaction date
Purchase
Price
2.79
Quantity 2,600 +inf%
Value US$7,252
WICKERSHAM GROVER T. Non-Executive Director
Transaction date
Purchase
Price
3.04
Quantity 10,000 +4.2%
Value US$30,442
Williams Julia Ann Non-Executive Director
Transaction date
Purchase
Price
3.21
Quantity 10,000 +512.8%
Value US$32,099
WICKERSHAM GROVER T. Non-Executive Director
Transaction date
Purchase
Price
2.81
Quantity 2,500 +4.9%
Value US$7,025
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-29 2026-09-28 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
96,916 +5.6%
366.45
US$1,181,795 		96,916 +5.6% 366.45 US$1,181,795
2026-09-15 2026-09-14 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
44,954 -42.4%
260.56
US$2,120,183 		44,954 -42.4% 260.56 US$2,120,183
2026-09-10 2026-09-09 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
30,683 -27.4%
122.07
US$3,432,691 		30,683 -27.4% 122.07 US$3,432,691
2026-09-10 2026-09-09 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
1,000 +16.7%
0.89
US$890 		1,000 +16.7% 0.89 US$890
2026-08-17 2026-08-14 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
1,000 +20.0%
1.21
US$1,210 		1,000 +20.0% 1.21 US$1,210
2026-08-10 2026-08-07 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
6,490 +0.6%
1.30
US$8,422 		6,490 +0.6% 1.30 US$8,422
2026-08-10 2026-08-06 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
15,000 +1.4%
1.30
US$19,443 		15,000 +1.4% 1.30 US$19,443
2026-07-22 2026-07-20 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
35,000 +3.4%
1.47
US$51,569 		35,000 +3.4% 1.47 US$51,569
2026-07-08 2026-07-07 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
1,000 +25.0%
1.43
US$1,430 		1,000 +25.0% 1.43 US$1,430
2026-07-02 2026-06-30 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
35,000 +3.5%
1.51
US$52,731 		35,000 +3.5% 1.51 US$52,731
2026-06-29 2026-06-29 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
5,172 +0.5%
1.52
US$7,884 		5,172 +0.5% 1.52 US$7,884
2026-06-29 2026-06-26 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
6,812 +0.7%
1.56
US$10,598 		6,812 +0.7% 1.56 US$10,598
2026-06-29 2026-06-25 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
9,442 +1.0%
1.53
US$14,435 		9,442 +1.0% 1.53 US$14,435
2026-06-29 2026-06-24 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
3,990 +0.4%
1.55
US$6,185 		3,990 +0.4% 1.55 US$6,185
2026-06-22 2026-06-22 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
5,000 +0.5%
1.66
US$8,296 		5,000 +0.5% 1.66 US$8,296
2026-06-22 2026-06-22 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
5,000 +0.5%
1.66
US$8,296 		5,000 +0.5% 1.66 US$8,296
2026-06-22 2026-06-17 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
3,264 +0.3%
1.61
US$5,268 		3,264 +0.3% 1.61 US$5,268
2026-06-22 2026-06-17 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
3,264 +0.3%
1.61
US$5,268 		3,264 +0.3% 1.61 US$5,268
2026-06-09 2026-06-08 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
1,000 +33.3%
1.55
US$1,550 		1,000 +33.3% 1.55 US$1,550
2026-06-09 2026-06-08 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
1,000 +33.3%
1.55
US$1,550 		1,000 +33.3% 1.55 US$1,550
2026-06-08 2026-06-08 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
7,000 +0.7%
1.61
US$11,304 		7,000 +0.7% 1.61 US$11,304
2026-06-08 2026-06-05 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
13,159 +1.4%
1.57
US$20,685 		13,159 +1.4% 1.57 US$20,685
2026-06-08 2026-06-04 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
8,230 +0.9%
1.65
US$13,547 		8,230 +0.9% 1.65 US$13,547
2026-05-18 2026-05-18 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
10,000 +1.1%
1.59
US$15,878 		10,000 +1.1% 1.59 US$15,878
2026-05-18 2026-05-15 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
7,120 +0.8%
1.65
US$11,747 		7,120 +0.8% 1.65 US$11,747
2026-05-18 2026-05-15 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
1,000 +50.0%
1.62
US$1,615 		1,000 +50.0% 1.62 US$1,615
2026-05-18 2026-05-14 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
15,000 +1.7%
1.72
US$25,862 		15,000 +1.7% 1.72 US$25,862
2026-05-18 2026-05-14 B Purchase
1.1
Edell Michael

Chief Executive Officer

Executive Director
2,000 +inf%
1.70
US$3,398 		2,000 +inf% 1.70 US$3,398
2026-04-30 2026-04-28 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
3,000 +0.3%
1.47
US$4,407 		3,000 +0.3% 1.47 US$4,407
2026-03-17 2026-03-17 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
19,725 +2.3%
1.79
US$35,355 		19,725 +2.3% 1.79 US$35,355
2026-03-17 2026-03-16 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
5,060 +0.6%
1.86
US$9,392 		5,060 +0.6% 1.86 US$9,392
2026-03-17 2026-03-13 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
146,249 +20.3%
1.95
US$285,434 		146,249 +20.3% 1.95 US$285,434
2026-02-19 2026-02-19 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
34,613 +5.2%
2.40
US$83,140 		34,613 +5.2% 2.40 US$83,140
2026-02-19 2026-02-18 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
10,481 +1.6%
2.29
US$24,001 		10,481 +1.6% 2.29 US$24,001
2026-02-19 2026-02-17 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
40,807 +6.6%
2.29
US$93,493 		40,807 +6.6% 2.29 US$93,493
2026-02-13 2026-02-13 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
15,390 +2.5%
1.89
US$29,106 		15,390 +2.5% 1.89 US$29,106
2026-02-13 2026-02-12 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
7,956 +1.3%
1.72
US$13,688 		7,956 +1.3% 1.72 US$13,688
2026-02-13 2026-02-11 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
8,000 +1.3%
1.73
US$13,874 		8,000 +1.3% 1.73 US$13,874
2026-02-06 2026-02-05 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
2,884 +0.5%
1.77
US$5,106 		2,884 +0.5% 1.77 US$5,106
2026-02-06 2026-02-04 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
5,685 +1.0%
1.82
US$10,373 		5,685 +1.0% 1.82 US$10,373
2026-02-03 2026-02-02 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
42,739 +7.8%
1.98
US$84,418 		42,739 +7.8% 1.98 US$84,418
2026-02-03 2026-02-02 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
42,739 +7.8%
1.98
US$84,418 		42,739 +7.8% 1.98 US$84,418
2026-02-03 2026-01-30 B Purchase
1.8
GLENBROOK CAPITAL MANAGEMENT
Large shareholder
5,399 +1.0%
1.87
US$10,106 		5,399 +1.0% 1.87 US$10,106
2025-11-19 2025-11-18 S Sale
2.9
Leach Jacob Steven
Non-Executive Director
62 -100.0%
2.71
US$168 		62 -100.0% 2.71 US$168
2025-11-17 2025-11-14 S Sale
2.3
Szot Matthew K
Non-Executive Director
1 -100.0%
2.75
US$3 		1 -100.0% 2.75 US$3
2019-10-22 2019-10-21 PlS Planned sale
Mayer Loretta Powers

Chief Scientific Officer

Executive Director
6,000 -1.8%
0.83
US$4,980 		6,000 -1.8% 0.83 US$4,980
2019-10-04 2019-10-02 PlS Planned sale
Dyer Cheryl Ann

Pres. & Chief Research Officer
6,000 -1.6%
0.93
US$5,575 		6,000 -1.6% 0.93 US$5,575
2019-08-16 2019-08-15 S Sale Mayer Loretta Powers

Chief Scientific Officer

Executive Director
20,000 -5.1%
1.19
US$23,734 		20,000 -5.1% 1.19 US$23,734
2019-08-16 2019-08-15 S Sale Dyer Cheryl Ann

Pres. & Chief Research Officer

Officer
20,000 -5.0%
1.21
US$24,100 		20,000 -5.0% 1.21 US$24,100
2019-08-16 2019-08-14 S Sale Mayer Loretta Powers

Chief Scientific Officer

Executive Director
20,000 -4.9%
1.24
US$24,756 		20,000 -4.9% 1.24 US$24,756
2019-08-16 2019-08-14 S Sale Dyer Cheryl Ann

Pres. & Chief Research Officer

Officer
20,000 -4.8%
1.18
US$23,622 		20,000 -4.8% 1.18 US$23,622
2019-07-18 2019-07-16 B Purchase
0.6
SIEGEL KENNETH S

CEO

Executive Director
696,296 +11119.4%
1.35
US$940,000 		696,296 +11119.4% 1.35 US$940,000
2018-08-15 2018-08-13 B Purchase Williams Julia Ann Non-Executive Director
1,000 +25.0%
1.15
US$1,150 		1,000 +25.0% 1.15 US$1,150
2018-08-15 2018-08-13 B Purchase Williams Julia Ann Non-Executive Director
6,000 +4.3%
1.15
US$6,900 		6,000 +4.3% 1.15 US$6,900
2018-08-15 2018-08-13 B Purchase Williams Julia Ann Non-Executive Director
4,000 +100.0%
1.15
US$4,600 		4,000 +100.0% 1.15 US$4,600
2018-06-25 2018-06-21 PlS Planned sale Mayer Loretta Powers

CEO & Chief Scientific Officer

Executive Director
6,000 -1.5%
2.13
US$12,780 		6,000 -1.5% 2.13 US$12,780
2017-12-26 2017-12-21 PlS Planned sale Mayer Loretta Powers

CEO & Chief Scientific Officer

Executive Director
6,000 -1.5%
0.67
US$4,026 		6,000 -1.5% 0.67 US$4,026
2017-12-05 2017-12-04 PlS Planned sale Dyer Cheryl Ann

Pres. & Chief Research Officer

Executive Director
6,000 -1.5%
0.82
US$4,921 		6,000 -1.5% 0.82 US$4,921
2017-11-28 2017-11-24 B Purchase Williams Julia Ann
1,700 +7.7%
0.90
US$1,525 		1,700 +7.7% 0.90 US$1,525
2017-11-22 2017-11-21 PlS Planned sale Mayer Loretta Powers

CEO & Chief Scientific Officer

Executive Director
6,000 -1.5%
0.89
US$5,363 		6,000 -1.5% 0.89 US$5,363
2017-11-03 2017-11-02 PlS Planned sale Dyer Cheryl Ann

Pres. & Chief Research Officer

Executive Director
6,000 -1.5%
2.72
US$16,339 		6,000 -1.5% 2.72 US$16,339
2017-10-24 2017-10-20 PlS Planned sale Mayer Loretta Powers

CEO & Chief Scientific Officer

Executive Director
6,000 -1.5%
1.52
US$9,126 		6,000 -1.5% 1.52 US$9,126
2017-10-03 2017-10-03 PlS Planned sale Dyer Cheryl Ann

Pres. & Chief Research Officer

Executive Director
6,000 -1.3%
1.97
US$11,808 		6,000 -1.3% 1.97 US$11,808
2017-09-26 2017-09-22 PlS Planned sale Mayer Loretta Powers

CEO & Chief Scientific Officer

Executive Director
6,000 -1.5%
1.79
US$10,740 		6,000 -1.5% 1.79 US$10,740
2017-09-07 2017-09-05 PlS Planned sale Dyer Cheryl Ann

Pres. & Chief Research Officer

Executive Director
6,000 -1.4%
2.31
US$13,834 		6,000 -1.4% 2.31 US$13,834
2017-08-23 2017-08-21 PlS Planned sale Mayer Loretta Powers

CEO & Chief Scientific Officer

Executive Director
6,000 -1.5%
2.37
US$14,221 		6,000 -1.5% 2.37 US$14,221
2017-08-18 2017-08-18 B Purchase Altman Andrew

Chief Operating Officer
2,028 +11.3%
2.46
US$4,987 		2,028 +11.3% 2.46 US$4,987
2017-08-18 2017-08-17 B Purchase Williams Julia Ann
9,000 +74.7%
2.80
US$25,200 		9,000 +74.7% 2.80 US$25,200
2017-08-18 2017-08-17 B Purchase Altman Andrew

Chief Operating Officer
14,372 +399.2%
2.81
US$40,332 		14,372 +399.2% 2.81 US$40,332
2017-08-18 2017-08-16 B Purchase Williams Julia Ann
100 +0.8%
2.75
US$275 		100 +0.8% 2.75 US$275
2017-08-18 2017-08-16 B Purchase Altman Andrew

Chief Operating Officer
1,000 +38.5%
2.82
US$2,820 		1,000 +38.5% 2.82 US$2,820
2017-08-18 2017-08-16 B Purchase Altman Andrew

Chief Operating Officer
2,600 +inf%
2.79
US$7,252 		2,600 +inf% 2.79 US$7,252
2017-07-27 2017-07-26 B Purchase WICKERSHAM GROVER T. Non-Executive Director
10,000 +4.2%
3.04
US$30,442 		10,000 +4.2% 3.04 US$30,442
2017-07-26 2017-07-26 B Purchase Williams Julia Ann Non-Executive Director
10,000 +512.8%
3.21
US$32,099 		10,000 +512.8% 3.21 US$32,099
2017-07-26 2017-07-25 B Purchase WICKERSHAM GROVER T. Non-Executive Director
2,500 +4.9%
2.81
US$7,025 		2,500 +4.9% 2.81 US$7,025
Explore more

More insider trading research around Senestech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America